Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Lopez-Berestein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1979 - 1981
San Juan City HospitalResidency, Internal Medicine, 1976 - 1979
Universidad de Navarra Faculty of MedicineClass of 1976
Certifications & Licensure
TX State Medical License 1980 - 2025
PR State Medical License Active through 2013
Publications & Presentations
PubMed
- Corrigendum to Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.Pinar Kanlikilicer, Recep Bayraktar, Merve Denizli, Mohammed H Rashed, Cristina Ivan
Ebiomedicine. 2025-01-01 - 1 citationsInhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B.Valeria Villarreal-García, José Roberto Estupiñan-Jiménez, Vianey Gonzalez-Villasana, Pablo E Vivas-Mejía, Marienid Flores-Colón
Hereditas. 2024-12-21 - MicroRNA-1307-3p contributes to breast cancer progression through PRM2.José Roberto Estupiñan-Jiménez, Valeria Villarreal-García, Vianey Gonzalez-Villasana, Pablo E Vivas-Mejia, Jose Manuel Vazquez-Guillen
Thoracic Cancer. 2024-11-01
Press Mentions
MD Anderson Research Highlights for December 19, 2022December 19th, 2022
New ERC President Mauro Ferrari Was Partner of Texas Cheater Anil SoodMay 17th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
